Dec 20, 2013
By AM740 Staff
A new cancer drug created at the Princess Margaret Cancer Centre in Toronto and the Jonsson Comprehensive Cancer Center at the University of California has received approval from both Health Canada and US Federal Drug Administration to proceed to a phase one clinical trial. The new drug has shown positive results when studied on human breast and ovarian cancers as well as colorectal, lung, melanoma, pancreatic and prostate cancers in animals. The phase one trial will involve a total of 30 people and will begin early in 2014 and run for about 18 months. The approval to proceed with the unnamed drug in human trials is a first for a Canadian cancer drug created by an academic institution. The Princess Margaret Cancer Centre is one of the top 5 cancer research centres in the world.